Bristol-Myers Squibb regulatory update

The FDA's Antiviral Drugs Advisory Committee unanimously recommended that Bristol-Myers's VIDEX (didanosine;ddI) be approved as a first-line antiretroviral therapy for HIV. Trials of VIDEX showed tha...